Senarillos, Edelito D.

HRN: 24-02-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/04/2023
11/12/2023
IV
1.5gm
TID
Cellulitis
Waiting Final Action 
11/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/04/2023
11/12/2023
IV
600mg
QID
Cellulitis
Waiting Final Action 
11/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/04/2023
11/04/2023
IV
4.5gm
Loading Dose
Sepsis
Waiting Final Action 
11/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/04/2023
11/12/2023
IV
2.25gm
TID
Sepsis
Waiting Final Action 
11/06/2023
MUPIROCIN 2%, 15G (TUBE)
11/06/2023
11/12/2023
TOPICAL
Apply On Affected Areas
Bid
Infected Wound L Leg, Cellulitis
Waiting Final Action 
11/07/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/07/2023
11/13/2023
TOPICAL
1%
BID
Infected Wound Left Leg
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: